Velos is a provider of clinical trial management solutions.
“We are pleased to welcome Velos to the WCG family,” Donald A. Deieso, executive chairman and CEO of WCG, said. “WCG is privileged to serve more than 2,800 institutions, and we are thrilled to empower them with technology solutions that will increase the efficiency of their research programs.”T
The acquisition will allow Velos to continue operating independently and remain at its headquarters in Fremont, California, Princeton-based WCG said. WCG will support Velos with capital, expertise and operational support.
“Our clients are recognized for their academic and clinical research excellence and scientific achievement,” John S. McIlwain, co-founder and CEO of Velos, said. “They are a critical part of the clinical research ecosystem. It is our mission to break down the silos and administrative barriers slowing their progress and limiting their growth, to enable them to accelerate breakthroughs in clinical care.”
Financial terms were not disclosed.